KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Novogen provides Cantrixil update-NRT.AX, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,515 Posts.
    lightbulb Created with Sketch. 337
    If the timeline was correct in 2015 for the drugs then there is no way known these delays would have taken this long - maybe 3 - 6 months delay but 12 months or more I think is saying "we may have been opptimistic with the timelines in 2014/15... another thing to consider is why would Yale be giving up 15% of its share in CanTx and hand over all the IP control to Novogen..

    Anyone feel like we're slowly slowly being fed reality to come back down after the expectations of 2014/2015 during/before the CR.... even JG has attempted to lower our expectations...

    The funny thing is we are taking out our frustrations against the current board - many of whom came after the CR campaign...
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.